ArticleInorganic chemistry2026
Evidence for the Formation of an Iron(III)-Indolenylperoxo Intermediate During Indole Dioxygenation: Similarities with Heme Dioxygenases.
Article in Inorganic chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Evidence for an iron(III)-indolenylperoxo (OOIn-) complex, [FeIII(OOIn)(TPP)(OCH3)]- (TPP = 5,10,15,20-tetraphenylporphyrinato2-) trapped at -78 °C, was obtained. The formation of this species was initiated by reaction of either FeIII(TPP)(Cl) in the presence of excess O2, OCH3- as axial ligand and base, and 3-methylindole, or from reaction of preformed [FeIII(O2•-)(TPP)(OCH3)]- with 3-methylindole under the same basic conditions. The new species was characterized by UV-vis, X-band EPR, and Mössbauer spectroscopies. Interestingly, the EPR spectra of [FeIII(OOIn)(TPP)(OCH3)]- exhibited two overlapping low-spin (S = 1/2) rhombic signals (A: g = [2.31, 2.20, 1.93]; B: g = [2.24, 2.15, 1.96]), whose ratios are sensitive to the amount of MeOH in the solvent mixture MeOH/toluene. The two sets of EPR signals (A and B) were assigned as arising from the presence or absence of hydrogen bonding between the OCH3- axial ligand and the solvent MeOH. This assignment was supported by analysis of ligand field splitting parameters derived from the EPR data. Addition of 1-methylimidazole (1-MeIm) to [FeIII(OOIn)(TPP)(OCH3)]- at -78 °C leads to conversion of the two overlapping rhombic EPR signals into a new, single S = 1/2 rhombic spectrum with g = [2.31, 2.18, 1.94] and a sharper Mössbauer spectrum. These data are consistent with substitution of OCH3- axial ligand by 1-MeIm to give FeIII(OOIn)(TPP)(1-MeIm). Thermal decay of the iron(III)-indolenylperoxo complex gives the ring-opened, dioxygenated product N-(2-acetylphenyl)formamide (75% by GC-MS). The capability of [FeIII(OOIn)(TPP)(OCH3)]- to convert into dioxygenated product indicates that iron indolenylperoxide is a possible intermediate of the indole dioxygenation process. This work has implications for the proposed mechanisms of tryptophan/indoleamine 2,3-dioxygenase (TDO/IDO) and demonstrates a feasible pathway for dioxygenation mediated by a single iron porphyrin complex.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.